• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[治疗指南制定中的经济与伦理问题]

[Economic and ethical aspects of the development of treatment guidelines].

作者信息

Lauterbach K W

机构信息

Instituts für Gesundheitsökonomie, Medizin und Gesellschaft.

出版信息

Z Arztl Fortbild Qualitatssich. 1997 Jun;91(3):277-82.

PMID:9312433
Abstract

The introduction of guidelines for diagnosis and therapy involves consequences for medical care which have to be considered both from the perspective of health economics and ethics. Four competing goals of guidelines can be distinguished which are discussed in this paper regarding their economic and ethical plausibility. Guidelines illustrate the fundamental potential and problems of microeconomic evaluations. The strength of these methods is to pursue well defined goals in health economics reliably and efficiently. Problems usually arise if there is no agreement on accepting these goals. The paper intends to show that important theories of a just distribution of health care resources arrive at different goals for guidelines, and recommendations are given to deal with this disagreement.

摘要

诊断和治疗指南的引入会给医疗保健带来一些后果,必须从卫生经济学和伦理学的角度加以考虑。可以区分出指南的四个相互竞争的目标,本文将从经济和伦理合理性方面对其进行讨论。指南阐明了微观经济评估的基本潜力和问题。这些方法的优势在于能够可靠且高效地追求卫生经济学中明确界定的目标。如果在接受这些目标方面无法达成共识,通常就会出现问题。本文旨在表明,关于医疗保健资源公正分配的重要理论会得出不同的指南目标,并针对这种分歧给出了建议。

相似文献

1
[Economic and ethical aspects of the development of treatment guidelines].[治疗指南制定中的经济与伦理问题]
Z Arztl Fortbild Qualitatssich. 1997 Jun;91(3):277-82.
2
[Assessment of the value of health-care services--the first step].[医疗保健服务价值评估——第一步]
Med Klin (Munich). 2008 May 15;103(5):321-4. doi: 10.1007/s00063-008-1039-6.
3
[Guidelines in surgery: from the viewpoint of health care economics].[外科手术指南:从医疗保健经济学的视角]
Langenbecks Arch Chir Suppl Kongressbd. 1997;114:72-3.
4
[Economic limits in oncology].[肿瘤学中的经济限制]
Z Arztl Fortbild Qualitatssich. 2000 Dec;94(10):833-6.
5
[Possibilities and limits of evaluation research: development of evaluation methods with an example].[评估研究的可能性与局限性:以一个例子说明评估方法的发展]
Langenbecks Arch Chir Suppl Kongressbd. 1997;114:617-24.
6
[Comments by the Working Group for Methods of Economic Evaluation in Health Care (AG MEG) to IQWiG's Draft Guidelines "Methods for Assessment of the Relation of Benefits to Costs in the German Statutory Health Care System"].[医疗保健经济评估方法工作组(AG MEG)对IQWiG《德国法定医疗保健系统中效益与成本关系评估方法》指南草案的评论]
Gesundheitswesen. 2008 Jun;70(6):e1-16. doi: 10.1055/s-2008-1077059.
7
[Practice guidelines in rehabilitation: infringement upon physicians' autonomy or foundation for better outcomes?].[康复实践指南:侵犯医生自主权还是实现更好治疗效果的基础?]
Rehabilitation (Stuttg). 2004 Oct;43(5):304-11. doi: 10.1055/s-2004-828434.
8
[Economics and ethics in public health?].[公共卫生中的经济学与伦理学?]
Gesundheitswesen. 1999 Jan;61(1):1-7.
9
[The dilemma of effectiveness and economic value of alternative medicine].[替代医学的有效性与经济价值困境]
Gesundheitswesen. 1997 May;59(5):297-301.
10
Procedures and methods of benefit assessments for medicines in Germany.德国药品效益评估的程序和方法。
Eur J Health Econ. 2008 Nov;9 Suppl 1:5-29. doi: 10.1007/s10198-008-0122-5.